Given the involvement of SAF-1 in regulating genes controlling tumor angiogenesis, cellular invasion, tumor cell proliferation and differentiation, and our previous finding of overexpression of SAF-1 in breast cancer [9], we aimed at developing a new approach to modulate SAF-1 by pharmacological treatment which would be an effective and promising method for cancer therapy. Here, MAZ is linked to breast cancer.